Endocrine therapy of prostatic carcinoma with slow release (depot) formulation of the LH-RH analog ICI 118630 (Zoladex)

Endocrine therapy of prostatic carcinoma with slow release (depot) formulation of the LH-RH analog ICI 118630 (Zoladex)

To investigate the clinical efficacy, safety and endocrinology of ICI 118630 (Zoladex) depot formulation at 3 different dose levels (0.9, 1.8 and 3.6 mg), 90 patients were randomized to receive either one of the 3 doses from April, 1985 to March, 1986 in 28 centers. The depot preparation was injecte...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 34(1988), 2 vom: 16. Feb., Seite 369-82
1. Verfasser: Usami, M (VerfasserIn)
Weitere Verfasser: Kotake, T, Matsuda, M, Okajima, E, Osafune, M, Akaza, H, Isurugi, K, Niijima, T, Aso, Y, Araki, T
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1988
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Clinical Trial English Abstract Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Delayed-Action Preparations Goserelin 0F65R8P09N Buserelin PXW8U3YXDV